GPNX
NOTIFICATION PROCESSED BY IB
12/18/2023
Back to search
Official data from USPTO
BRYVORA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
12/18/2023
Trademark type
Word
Nice classes
5
Filing date
07/19/2022
Registration date
05/02/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2023
Last transaction
05/02/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
HSU, FONG
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the aforementioned excluding pharmaceutical preparations for the treatment of genetic diseases and disorders and pharmaceutical preparations for use in enzyme therapy
Publications
History of USPTO decisions and trademark events.
33 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/02/2023
IRRH
IRREGULARITY FROM IB EXAMINED BY MPU
11/02/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
11/02/2023
IRFI
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
09/18/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/10/2023
FIMP
FINAL DISPOSITION PROCESSED
08/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2023
PUBO
PUBLISHED FOR OPPOSITION
02/14/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/13/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/25/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2023
ATRV
ATTORNEY REVIEW COMPLETED
01/10/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
01/10/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
01/08/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/26/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/26/2022
CNRT
NON-FINAL ACTION WRITTEN
10/25/2022
DOCK
ASSIGNED TO EXAMINER
10/17/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/01/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/20/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
08/12/2022
Continuous trademark protection
Get notified about every new filing that threatens BRYVORA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.